Samsung Biologics
207940.KS
#399
Rank
NZ$85.45 B
Marketcap
$1,201
Share price
0.90%
Change (1 day)
27.94%
Change (1 year)

Market capitalization of Samsung Biologics (207940.KS)

Market cap: NZ$85.45 Billion

As of November 2024 Samsung Biologics has a market cap of NZ$85.45 Billion. This makes Samsung Biologics the world's 399th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Samsung Biologics from 2016 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$85.45 B29.36%
2023NZ$66.06 B-8.95%
2022NZ$72.55 B-1.3%
2021NZ$73.51 B5.44%
2020NZ$69.71 B89.52%
2019NZ$36.78 B7.72%
2018NZ$34.15 B5.68%
2017NZ$32.31 B170.06%
2016NZ$11.96 B

End of Day market cap according to different sources

On Nov 9th, 2024 the market cap of Samsung Biologics was reported to be:

NZ$85.53 Billion
by Yahoo Finance info icon info icon
NZ$85.45 Billion
by CompaniesMarketCap info icon info icon